1. [P3–418]: PARIETAL WHITE MATTER LESIONS IN ALZHEIMER's DISEASE ARE ASSOCIATED WITH CORTICAL NEURODEGENERATIVE PATHOLOGY AND NOT WITH SMALL‐VESSEL DISEASE. (1st July 2017) Authors: McAleese, Kirsty E.; Walker, Lauren; Graham, Sophie; Erskine, Daniel; Moya, Elisa LJ.; Johnson, Mary; Colloby, Sean J.; Dey, Madhurima; Taylor, John‐Paul; Thomas, Alan; McKeith, Ian G.; DeCarli, Charles S.; Attems, Johannes Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 23 Page Start: P1125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Discontinuation and primary care visits in nonvalvular atrial fibrillation patients treated with apixaban or warfarin. (8th February 2019) Authors: Ramagopalan, Sreeram V; Graham, Sophie; Carroll, Robert; Raluy-Callado, Mireia; Nordstrom, Beth L; Donaldson, Robert; Colby, Chris; Mehmud, Faisal; Alikhan, Raza Journal: Journal of comparative effectiveness research Issue: Volume 8:Number 6(2019) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Extravascular fibrinogen in the white matter of Alzheimer's disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer's disease. (29th January 2019) Authors: McAleese, Kirsty E.; Graham, Sophie; Dey, Madhurima; Walker, Lauren; Erskine, Daniel; Johnson, Mary; Johnston, Eleanor; Thomas, Alan J.; McKeith, Ian G.; DeCarli, Charles; Attems, Johannes Journal: Brain pathology Issue: Volume 29:Number 3(2019) Page Start: 414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Factors associated with non-prescription of oral anticoagulant treatment in non-valvular atrial fibrillation patients with dementia: a CPRD–HES study. (2nd April 2020) Authors: Besford, Megan; Graham, Sophie; Sammon, Cormac; Mehmud, Faisal; Allan, Victoria; Alikhan, Raza; Ramagopalan, Sreeram Journal: Age and ageing Issue: Volume 49:Number 4(2020) Page Start: 679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. (3rd July 2019) Authors: Harris, Linda; Graham, Sophie; MacLachlan, Sharon; Exuzides, Alex; Jacob, Saiju Journal: Journal of medical economics Issue: Volume 22:Number 7(2019) Page Start: 691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lack of data sharing in observational studies. (24th October 2017) Authors: McDonald, Laura; Schultze, Anna; Simpson, Alex; Graham, Sophie; Wasiak, Radek; Ramagopalan, Sreeram V Journal: BMJ Issue: Volume 359(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Reply: Re: Harris L, Graham S, MacLachlan S, et al. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ. 2019;22(7):691–697. (1st January 2021) Authors: Harris, Linda; Graham, Sophie; MacLachlan, Sharon; Exuzides, Alex; Jacob, Saiju Journal: Journal of medical economics Issue: Volume 24:Number 1(2021) Page Start: 864 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The aetiology of frontal white matter lesions in Alzheimer's disease are associated with both neurodegenerative and ischemic mechanisms: Human neuropathology/tau. (7th December 2020) Authors: McAleese, Kirsty E.; Miah, Mohi; Graham, Sophie; Baker, Georgie; Walker, Lauren; DeCarli, Charles; Koss, David; Attems, Johannes Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗